ADIL - Adial Pharmaceuticals Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-05-08)
Last
 0.62		 Change
 ⇓ -0.03   (0.00%)		 Volume
  321,856
Open
 0.64		 High
 0.66		 Low
 0.60
8EMA (Daily)
 0.67		 40EMA (Daily)
 0.71		 50EMA (Daily)
 0.73		 STO (Daily)
 7.798		 MACD Hist (Daily)
 -0.012
8EMA (Weekly)
 0.687		 40EMA (Weekly)
 0.92		 50EMA (Weekly)
 0.97		 STO (Weekly)
 14.167		 MACD Hist (Weekly)
 -0.002
Company Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com